Showing results (31-40 of 151) with videos related to
Sort By:
Pageof 16
Journal of Diabetes Science and Technology|June 16, 2016
Glycemic Control, Renal Complications, and Current Smoking in Relation to Excess Risk of Mortality in Persons With Type 1 DiabetesElsa Ahlén, Aldina Pivodic, Hans Wedel, et al.BMJ Open Diabetes Research & Care|October 5, 2021
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UKAntonio González-Pérez, Maria Saez, David Vizcaya, et al.Diabetes Care|July 10, 2021
Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88Marcus Lind, Henrik Imberg, Ruth L Coleman, et al.Diabetes Care|June 7, 2019
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical TrialTina Vilsbøll, Ella Ekholm, Eva Johnsson, et al.Cardiovascular Diabetology|January 20, 2020
Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort studyShilan Seyed Ahmadi, Ann-Marie Svensson, Aldina Pivodic, et al.Lancet (London, England)|June 28, 2011
Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational studyMarcus Lind, Ioannis Bounias, Marita Olsson, et al.European Heart Journal|November 13, 2012
The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trialLinda G Mellbin, Klas Malmberg, Lars Rydén, et al.Thrombosis Research|September 15, 2015
von Willebrand activation factor as a marker of mortality, cardiovascular events, and bleeding complications in patients treated with oral anticoagulantsMarcus Lind, Lars Johansson, Torbjörn K Nilsson, et al.Thrombosis Research|July 10, 2013
Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatmentMarcus Lind, Jan-Håkan Jansson, Torbjörn K Nilsson, et al.Diabetes Care|June 13, 2013
Relationship between overweight and obesity with hospitalization for heart failure in 20,985 patients with type 1 diabetes: a population-based study from the Swedish National Diabetes RegistryDaniel Vestberg, Annika Rosengren, Marita Olsson, et al.Pageof 16